Brinker Capital Investments’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,385
| Closed | -$663K | – | 2047 |
|
|
2025
Q1 | $663K | Buy |
10,385
+2,358
| +29% | +$150K | 0.01% | 1277 |
|
|
2024
Q4 | $976K | Sell |
8,027
-1,731
| -18% | -$210K | 0.01% | 1070 |
|
|
2024
Q3 | $1.22M | Sell |
9,758
-177
| -2% | -$22.1K | 0.01% | 944 |
|
|
2024
Q2 | $1.57M | Sell |
9,935
-161
| -2% | -$25.4K | 0.02% | 765 |
|
|
2024
Q1 | $1.31M | Buy |
10,096
+3,123
| +45% | +$404K | 0.01% | 866 |
|
|
2023
Q4 | $716K | Sell |
6,973
-7,183
| -51% | -$737K | 0.01% | 1077 |
|
|
2023
Q3 | $1.72M | Buy |
14,156
+1,198
| +9% | +$145K | 0.02% | 683 |
|
|
2023
Q2 | $1.48M | Buy |
12,958
+8,687
| +203% | +$995K | 0.02% | 784 |
|
|
2023
Q1 | $589K | Buy |
4,271
+313
| +8% | +$43.1K | 0.01% | 1085 |
|
|
2022
Q4 | $513K | Sell |
3,958
-339
| -8% | -$43.9K | 0.01% | 969 |
|
|
2022
Q3 | $475K | Buy |
4,297
+150
| +4% | +$16.6K | 0.01% | 963 |
|
|
2022
Q2 | $311K | Sell |
4,147
-1,506
| -27% | -$113K | 0.01% | 1153 |
|
|
2022
Q1 | $442K | Sell |
5,653
-36
| -0.6% | -$2.82K | 0.01% | 1092 |
|
|
2021
Q4 | $512K | Sell |
5,689
-1,853
| -25% | -$167K | 0.01% | 1045 |
|
|
2021
Q3 | $586K | Hold |
7,542
| – | – | 0.01% | 929 |
|
|
2021
Q2 | $586K | Buy |
7,542
+2,301
| +44% | +$179K | 0.01% | 982 |
|
|
2021
Q1 | $391K | Sell |
5,241
-3,115
| -37% | -$232K | 0.01% | 969 |
|
|
2020
Q4 | $1.43M | Buy |
8,356
+3,854
| +86% | +$657K | 0.02% | 623 |
|
|
2020
Q3 | $632K | Buy |
+4,502
| New | +$632K | 0.01% | 834 |
|